[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"University of Tartu\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":304},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,12,0,[8,45,73,102,132,153,172,190,214,240,258,279],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100639278","predictors-of-transmural-non-occlusive-mesenteric-ischemia-in-icu-patients-with-suspected-acute-mesenteric-ischemia-100639278",false,"NCT07610356","Predictors of Transmural Non-Occlusive Mesenteric Ischemia in ICU Patients With Suspected Acute Mesenteric Ischemia","Mesenteric Ischemia in the ICU: A Prospective Observational Study Across Estonian Regional Hospitals","AMESI-EST","Inclusion criteria\n\n\\- Adult ICU patients in whom clinical suspicion of acute mesenteric ischemia is raised during their ICU stay.\n\nExclusion criteria\n\n* Patients who develop acute mesenteric ischemia outside of the intensive care unit,\n* Confirmed strangulating bowel obstruction,\n* Individuals younger than 18 years,\n* Chronic mesenteric ischemia without an acute event.","ALL","18 Years",{"count":20,"type":21},150,"ESTIMATED","OBSERVATIONAL","Acute mesenteric ischemia (AMI) is a rare but life-threatening condition associated with high mortality and major diagnostic challenges due to nonspecific clinical presentation and limited reliable biomarkers. Critically ill patients in the intensive care unit (ICU) are at particularly high risk of non-occlusive mesenteric ischemia (NOMI), a subtype of AMI characterized by impaired mesenteric perfusion without large-vessel occlusion. Despite advances in imaging, the diagnosis of NOMI remains difficult, and data specifically focusing on ICU patients with suspected AMI are limited.\n\nThis prospective observational multicenter study aims to identify independent predictors of transmural NOMI among ICU patients with suspected AMI. In addition, the study will describe demographics, comorbidities, clinical presentation, laboratory findings, diagnostic imaging, management strategies, and outcomes among ICU patients with NOMI, other forms of AMI, and patients with suspected but unconfirmed AMI. Consecutive adult ICU patients in whom clinical suspicion of AMI arises during ICU stay will be included across Estonian regional hospitals. The study is a local continuation of the international AMESI study, with a specific focus on critically ill ICU patients.",[25,26],"Non-Occlusive Mesenteric Ischaemia (NOMI)","Acute Mesenteric Ischemia",[28,29,30,31],"Acute mesenteric ischemia","non-occlusive mesenteric ischemia","transmural necrosis","predictors","RECRUITING","2026-05-21",{"date":35,"type":36},"2026-05-28","ACTUAL",{"date":38,"type":36},"2022-06-06",{"date":40,"type":21},"2026-09-05",{"name":42,"class":43},"University of Tartu","OTHER",2,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":52,"sex":17,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":4,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},"100628784","the-effect-of-playful-physiotherapy-intervention-100628784","NCT07466147","The Effect of Playful Physiotherapy Intervention","The Effect of Playful Physiotherapy Intervention on Emotional Self-regulation in Children Aged 7-12 Years Old With Neurodevelopmental and Behavioral Special Needs in a Rehabilitation Setting.","Inclusion Criteria:\n\n* Age 5-12 years;\n* Clinical diagnosis: ADHD, ASD, behavioral regulation difficulties, and\u002For social adaptation difficulties in group settings;\n* Participation in physiotherapy at ProVida Clinic or assessment by the clinic's rehabilitation team regarding suitability for participation;\n* Ability to participate in movement- and play-based activities in a group format;\n* Proficiency in Estonian;\n* No prior participation in a similar group.\n\nExclusion Criteria:\n\n* Acute or chronic medical condition that prevents active participation;\n* Severe cognitive or sensory impairment that prevents understanding of activities or safe participation;\n* Situations in which the child's participation may disrupt group functioning or compromise safety.",true,"7 Years","12 Years",{"count":56,"type":21},25,"INTERVENTIONAL",[59],"NA","The goal of this quasi-experimental study is to evaluate the changes in emotional, behavioral, and psychosocial functioning of children aged 7-12 following a playful physiotherapy intervention. The study focused on the potential effects of a play- and body-based intervention on children's daily functioning, based on parent-reported assessments\n\nThe main question\\[s\\] it aims to answer \\[is\u002Fare\\]:\n\nParticipants will be evaluated based on the Strengths and Difficulties Questionnaire and KIDSCREEN-27 before and after the playful physiotherapy intervention programme.",[62,63],"Attention Deficit Hyperactivity Disorder","Autism Spectrum Disorder","2026-04-28",{"date":66,"type":36},"2026-05-05",{"date":68,"type":21},"2026-05",{"date":70,"type":21},"2027-02",{"name":42,"class":43},1,{"id":74,"slug":75,"hasResults":11,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":4,"eligibilityCriteria":79,"healthyVolunteers":11,"sex":17,"minAge":80,"maxAge":81,"enrollmentInfo":82,"targetDuration":4,"studyType":57,"phases":84,"briefSummary":85,"conditions":86,"keywords":88,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":72},"100630736","the-effect-of-pain-education-group-therapy-and-its-impact-on-chronic-pain-kinesiophobia-and-physical-activity-100630736","NCT07491549","The Effect of Pain Education Group Therapy and Its Impact on Chronic Pain, Kinesiophobia, and Physical Activity","Physical Activity in Patients With Chronic Pain, Its Adherence to WHO Physical Activity Recommendations, and Its Associations With Kinesiophobia, Central Sensitization, Depression, and Pain Intensity","Inclusion Criteria:\n\n* Pain lasting longer than 3 months,\n* Consequences resulting from long-term pain (such as decreased physical activity, sleep disturbances, fatigue, low mood, etc.)\n\nExclusion Criteria:\n\n* Surgery that occurred less than 3 months prior\n* Fracture or limb trauma that occurred less than 3 months prior","16 Years","65 Years",{"count":83,"type":21},50,[59],"The goal of this clinical trial is to learn if pain knowledge group intervention among chronic pain patients would influence their level of physical activity, pain intensity, depression, kinesiophobia and central sensitization. The main question it aims to answer is:\n\nPrimary hypothesis: pain education will decrease participants' depression and pain intensity and increase their physical activity.\n\nThere is no comparison group.\n\nParticipants will participate in a 6-week pain knowledge intervention where they will be learning about sleep, stress models, physical activity benefits, pain neurobiology, mindfulness, pain medication.",[87],"Chronic Pain",[89,90,91,92,93],"chronic pain","depression","pain education","physical activity","kinesiophobia","2026-03-24",{"date":96,"type":36},"2026-03-30",{"date":98,"type":21},"2026-04-01",{"date":100,"type":21},"2030-12-30",{"name":42,"class":43},{"id":103,"slug":104,"hasResults":11,"nctId":105,"briefTitle":106,"officialTitle":107,"acronym":108,"eligibilityCriteria":109,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":110,"enrollmentInfo":111,"targetDuration":4,"studyType":57,"phases":113,"briefSummary":114,"conditions":115,"keywords":120,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":124,"lastUpdatePostDateStruct":125,"startDateStruct":127,"completionDateStruct":129,"leadSponsor":131,"locationsCount":44},"100614199","central-haemodynamics-and-pacing-for-av-block-100614199","NCT07276490","Central Haemodynamics and Pacing for AV Block","The Pacing in Atrioventricular Block: a Comparative Evaluation of Central Haemodynamics, Cardiac Function, and Quality of Life","PACE-CCQ","Inclusion Criteria:\n\n* Age 18-80 years\n* Diagnosis of atrioventricular block\n* Expected survival \\>1 year\n\nExclusion Criteria:\n\n* Reduced left ventricular ejection fraction (EF \\\u003C45%)\n* Expected ventricular pacing burden \\\u003C20%\n* Inter-arm systolic blood pressure difference \\>15 mmHg\n* Percutaneous coronary intervention or coronary artery bypass surgery within the last 30 days\n* Secondary hypertension\n* Orthostatic hypotension\n* Clinically significant valvular heart disease\n* Congenital heart disease\n* Pulse wave analysis or pulse wave velocity measurement cannot be reliably performed\n* Pregnancy or breastfeeding\n* Withdrawal of consent by the subject\n* Loss of contact during the study","80 Years",{"count":112,"type":21},124,[59],"A randomized, single-blind study comparing two pacing strategies in patients with atrioventricular block requiring permanent pacemaker implantation. This trial evaluates the impact of conduction system pacing (left bundle branch area pacing) versus standard right ventricular pacing on central hemodynamics, cardiac function, and patient quality of life over 12 months. The study will enroll 124 patients from two Estonian tertiary hospitals and measure central systolic arterial pressure as the primary outcome, with secondary assessments of arterial stiffness, echocardiographic parameters, electrical activation patterns, and quality of life scores.",[116,117,118,119],"Atrioventricular Block","Pacing Therapy","Right Ventricular Pacing","Conduction System Pacing",[121,122,123],"conduction system pacing","atrioventricular block","right ventricular pacing","2026-03-06",{"date":126,"type":36},"2026-03-09",{"date":128,"type":36},"2025-11-28",{"date":130,"type":21},"2027-12-31",{"name":42,"class":43},{"id":133,"slug":134,"hasResults":11,"nctId":135,"briefTitle":136,"officialTitle":137,"acronym":4,"eligibilityCriteria":138,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":139,"targetDuration":4,"studyType":57,"phases":141,"briefSummary":142,"conditions":143,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":145,"lastUpdatePostDateStruct":146,"startDateStruct":148,"completionDateStruct":150,"leadSponsor":152,"locationsCount":72},"100491353","study-about-contrast-media-100491353","NCT05678023","Study About Contrast Media","Multicentre Randomized Trial on the Timing and Effect of Contrast Media on Patients with Adhesive Small Bowel Obstruction","Inclusion Criteria:\n\n* Patients 18 years or older\n* Adhesive small bowel obstruction diagnosed (clinical, laboratory and radiologic evaluation\n* No peritonitis present, no need for an emergent surgery\n* Patients sign an informed consent\n\nExclusion Criteria:\n\n* Patients younger than 18 yeas\n* Patients with mechanical small bowel obstruction caused by incarcerated hernias\n* Patients with mechanical small bowel obstruction caused by carcinomatosis\n* Patients with paralytic small bowel obstruction\n* Patients who have undergone surgery within 6 weeks\n* Patients who do not want to be enrolled in the study",{"count":140,"type":21},120,[59],"Patients hospitalized with adhesive small bowel obstruction (SBO) are randomized to 2 study groups at admission after signing an informed consent form. Water-soluble contrast media (CM) will be administered after 4 or after 24 hours of nasogastric- tube decompression.",[144],"Small Bowel Obstruction","2025-03-25",{"date":147,"type":36},"2025-03-30",{"date":149,"type":36},"2023-09-01",{"date":151,"type":21},"2025-08-01",{"name":42,"class":43},{"id":154,"slug":155,"hasResults":11,"nctId":156,"briefTitle":157,"officialTitle":158,"acronym":159,"eligibilityCriteria":160,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":161,"targetDuration":163,"studyType":22,"phases":4,"briefSummary":164,"conditions":165,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":166,"lastUpdatePostDateStruct":167,"startDateStruct":168,"completionDateStruct":169,"leadSponsor":171,"locationsCount":72},"100550329","the-feasibility-of-a-radiological-score-based-on-ct-signs-for-recognizing-salvageable-bowel-in-acute-mesenteric-ischemia-100550329","NCT06445660","The Feasibility of a Radiological Score Based on CT Signs for Recognizing Salvageable Bowel in Acute Mesenteric Ischemia","The Feasibility of a Radiological Score Based on Quantified Analysis of Computed Tomography Signs for Recognizing Salvageable Bowel in Acute Mesenteric Ischemia: A Retrospective Analysis of Prospective Study","AMESIradiol","Inclusion Criteria:\n\n* Participant in AMESI study\n* confirmed or suspected acute mesenteric ischaemia\n* CT scan of the entire abdominal cavity \u002F full body using intravenous contrast media is available\n\nExclusion Criteria:\n\n* Scans without the use of an intravenous contrast media or those covering only a partial area of the abdomen will be excluded.",{"count":162,"type":21},200,"1 Year","Computed tomography (CT) is the standard modality for scanning patients with critical acute abdominal conditions, including suspected acute mesenteric ischemia (AMI). CT imaging can potentially differentiate between reversible and irreversible ischaemic damage of the bowel. This moment is pivotal in selecting the treatment strategy for AMI - in the absence of irreversible damage; reperfusion therapy can preserve intestinal viability, thereby avoiding the need for bowel resection. The present study tests the hypothesis that combining several symptoms may enhance the diagnostic performance of CT scanning in detecting salvageable bowel in patients with AMI. This study is an ancillary component of the AMESI study (Clinical Trials: NCT05218863) - a prospective, multicentre observational study aimed at identifying the incidence and describing the outcomes of acute mesenteric ischemia (AMI) in adult hospitalized patients. The ultimate purpose of the present study is to create a computed tomography-based radiological score for the assessment of bowel viability in patients with AMI.",[26],"2025-03-24",{"date":145,"type":36},{"date":38,"type":36},{"date":170,"type":21},"2025-05-31",{"name":42,"class":43},{"id":173,"slug":174,"hasResults":11,"nctId":175,"briefTitle":176,"officialTitle":176,"acronym":4,"eligibilityCriteria":177,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":81,"enrollmentInfo":178,"targetDuration":4,"studyType":57,"phases":180,"briefSummary":181,"conditions":182,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":166,"lastUpdatePostDateStruct":184,"startDateStruct":185,"completionDateStruct":187,"leadSponsor":189,"locationsCount":72},"100529477","effect-of-psychedelic-vr-augmented-therapy-on-patients-with-clinical-depression-100529477","NCT06174285","Effect of Psychedelic VR-augmented Therapy on Patients With Clinical Depression","Inclusion Criteria:\n\n* Persistent depressive symptoms observed during the initial screening and confirmed at baseline, as determined through a comprehensive psychiatric evaluation.\n* Provision of written informed consent by the participant.\n* Fluent in Estonian as a native language.\n\nExclusion Criteria:\n\n* Presence of significant impairments in vision, hearing, or balance.\n* Active suicidal ideation or current engagement in self-harm behaviors. Note: Individuals meeting this criterion will be directed to suitable crisis intervention services.\n* Established diagnosis of bipolar disorder.\n* Manifestation of psychotic symptoms.\n* History of schizophrenia, either personally or within two generations of the family lineage.\n* Ongoing diagnosis of epilepsy, dementia, or any other neurological condition that could interfere with the effective utilization of virtual reality (VR) technology.\n* Susceptibility to motion sickness.",{"count":179,"type":21},45,[59],"Research has demonstrated that psychedelic compounds possess significant therapeutic potential for a variety of disorders, including depression. Despite these findings, the underlying mechanisms driving the therapeutic efficacy of psychedelics remain elusive. Furthermore, there exists a debate over the contribution of the subjective psychedelic experience to their therapeutic benefits. In this study, virtual reality (VR) is utilized as a tool to replicate the subjective experiences induced by psychedelics, aiming to explore their impact on depressive symptoms within a clinical sample.\n\nThe primary objective of this research is to examine the influence of psychedelic-like phenomenology, as simulated through VR, on depressive symptoms. The study is structured into two distinct arms: the experimental condition features 'Psyrreal,' a VR experience designed to emulate psychedelic effects and the control condition which includes 'Routine Realms,' an analogous VR experience devoid of psychedelic elements. A third waiting list condition may be included, dependent on the availability of sufficient participants and resources. Additionally, the study seeks to identify and analyze various potential mediators that might underpin the therapeutic outcomes observed.",[183],"Depression",{"date":145,"type":36},{"date":186,"type":36},"2023-11-06",{"date":188,"type":21},"2026-06-30",{"name":42,"class":43},{"id":191,"slug":192,"hasResults":11,"nctId":193,"briefTitle":194,"officialTitle":194,"acronym":4,"eligibilityCriteria":195,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":196,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":198,"conditions":199,"keywords":201,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":166,"lastUpdatePostDateStruct":207,"startDateStruct":209,"completionDateStruct":211,"leadSponsor":213,"locationsCount":72},"100528757","standardising-and-simplifying-the-global-leadership-initiative-on-malnutrition-glim-for-its-more-general-application-100528757","NCT06164925","Standardising and Simplifying the Global Leadership Initiative on Malnutrition (GLIM) for Its More General Application","Inclusion Criteria:\n\n* Age of 18+ years\n* Able and willing to sign the consent form\n* Inpatients of the Tartu University Hospital\n* Admitted within 72 hours before enrolment\n\nExclusion Criteria:\n\n* Age of \\\u003C18 years\n* Inability or refusal to sign the consent form\n* Pregnant or lactating women\n* More than 72 hours passed since admission\n* Patients isolating with an infection",{"count":197,"type":21},300,"This observational study of aims to test whether and how the results of GLIM change when using different approaches and methods to carry out its components.",[200],"Malnutrition",[202,203,204,205,206],"GLIM criteria","GLIM","nutrition assessment","nutrition screening","muscle mass",{"date":208,"type":36},"2025-03-28",{"date":210,"type":36},"2023-12-13",{"date":212,"type":21},"2025-06-30",{"name":42,"class":43},{"id":215,"slug":216,"hasResults":11,"nctId":217,"briefTitle":218,"officialTitle":219,"acronym":4,"eligibilityCriteria":220,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":221,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":223,"conditions":224,"keywords":226,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":232,"lastUpdatePostDateStruct":233,"startDateStruct":235,"completionDateStruct":237,"leadSponsor":239,"locationsCount":72},"100583250","integrating-bia-and-egfr-for-nutritional-status-in-hemodialysis-patients-100583250","NCT06873880","Integrating BIA and eGFR for Nutritional Status in Hemodialysis Patients","Integrating Bioelectrical Impedance Analysis and Estimated Glomerular Filtration Rate: A Novel Approach to Assessment of Nutritional Status of Hemodialysis Patients","Inclusion Criteria:\n\nChronic kidney disease Hemodialysis for at least 6 months\n\nExclusion Criteria:\n\nPregnancy Lactation Major second pathology Pacemaker Recent surgery",{"count":222,"type":21},30,"This study looks at how measurements of body composition from Bioelectrical Impedance Analysis (BIA) and estimates of kidney function (eGFR) can be applied together to better assess the health of people on hemodialysis. Many dialysis patients struggle with malnutrition, muscle loss, and fluid imbalances, but current assessment methods rely on unsophisticated tests and observations. By combining BIA and eGFR, this study aims to provide a more accurate and non-invasive way to monitor nutrition and overall health, which could lead to better treatment decisions and improved patient outcomes.",[225],"Chronic Kidney Disease Requiring Chronic Dialysis",[227,228,229,230,231],"Dialysis","Bioelectrical impedance","Nutrition","Body composition","Renal impairment","2025-03-10",{"date":234,"type":36},"2025-03-13",{"date":236,"type":36},"2025-02-10",{"date":238,"type":21},"2025-07-30",{"name":42,"class":43},{"id":241,"slug":242,"hasResults":11,"nctId":243,"briefTitle":244,"officialTitle":244,"acronym":4,"eligibilityCriteria":245,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":246,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":247,"conditions":248,"keywords":4,"overallStatus":251,"whyStopped":4,"lastUpdateSubmitDate":236,"lastUpdatePostDateStruct":252,"startDateStruct":254,"completionDateStruct":256,"leadSponsor":257,"locationsCount":4},"100579800","calf-circumference-adjusted-for-body-composition-to-assess-muscle-mass-100579800","NCT06829004","Calf Circumference Adjusted for Body Composition to Assess Muscle Mass","Inclusion Criteria:\n\nBooked to undergo bone density scanning (DEXA) at Tartu University Hospital\n\nExclusion Criteria:\n\nIsolation for infectious disease Pregnancy and lactation Unable to understand or follow study protocol",{"count":20,"type":21},"Muscle mass is a critical indicator for malnutrition and sarcopenia assessment. Anthropometric measurements like calf circumference (CC) could be a simple and cost-effective alternative when gold standard methods are not available. However, CC is probably less accurate for estimating muscle mass in female patients and patients with obesity. This study investigates whether adjusting CC using mid-upper arm circumference (MUAC) improves muscle mass estimation in patients with obesity. If validated, this correction method would serve as a simple clinical tool for muscle mass assessment.",[249,250],"Muscle Mass","Obesity and Overweight","NOT_YET_RECRUITING",{"date":253,"type":36},"2025-02-17",{"date":255,"type":21},"2025-02-15",{"date":188,"type":21},{"name":42,"class":43},{"id":259,"slug":260,"hasResults":11,"nctId":261,"briefTitle":262,"officialTitle":263,"acronym":264,"eligibilityCriteria":265,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":266,"targetDuration":4,"studyType":57,"phases":268,"briefSummary":269,"conditions":270,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":271,"lastUpdatePostDateStruct":272,"startDateStruct":274,"completionDateStruct":276,"leadSponsor":278,"locationsCount":44},"100532447","biomarkers-in-prediction-of-ami-100532447","NCT06212921","Biomarkers in Prediction of AMI","Biomarkers In Prediction of Acute Mesenteric Ischaemia: a Prospective Multicentre Study (BIPAMI Study)","BIPAMI","Inclusion Criteria:\n\n* Age 18 years or older\n* Initial decision in favour of further diagnostics of mesenteric ischaemia\n\nExclusion Criteria:\n\n* Age \\\u003C18 years\n* Consent declined by patient or next of kin (delayed consent)\n* Chronic mesenteric ischaemia without an acute event\n* Immediate decision for withdrawal of further diagnostics and active treatment\n* Referral from another hospital with already established diagnosis of AMI\n* AMI diagnosed at surgery without previously having been considered",{"count":267,"type":21},250,[59],"Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.",[26],"2024-11-27",{"date":273,"type":36},"2024-12-03",{"date":275,"type":36},"2024-10-14",{"date":277,"type":21},"2025-12",{"name":42,"class":43},{"id":280,"slug":281,"hasResults":11,"nctId":282,"briefTitle":283,"officialTitle":284,"acronym":285,"eligibilityCriteria":286,"healthyVolunteers":11,"sex":17,"minAge":81,"maxAge":287,"enrollmentInfo":288,"targetDuration":4,"studyType":57,"phases":289,"briefSummary":290,"conditions":291,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":296,"lastUpdatePostDateStruct":297,"startDateStruct":299,"completionDateStruct":301,"leadSponsor":303,"locationsCount":72},"100540912","effects-of-remote-ischaemic-preconditioning-in-cemented-hip-arthroplasty-100540912","NCT06323018","Effects of Remote Ischaemic Preconditioning in Cemented Hip Arthroplasty.","Effects of Remote Ischaemic Preconditioning in Cemented Total Hip Arthroplasty: Randomized Controlled Trial","PRINCIPAL","Inclusion Criteria:\n\n* age \\>65 years\n* undergoing total hip cemented hip arthroplasty\n\nExclusion Criteria:\n\n* previously diagnosed peripheral artery disease on both upper limb\n* RIPC is contraindicated","90 Years",{"count":162,"type":21},[59],"Total joint arthroplasty is one of the best treatment options for end-stage osteoarthritis. Cemented hip arthroplasty is mainly indicated for elderly patients with poor bone quality and multiple comorbidities. Bone cement implantation syndrome is associated with cemented hip arthroplasty and it has been shown to increase cardiovascular and renal complication and brain damage postoperatively. The aim of this project is to elucidate whether remote-ischemic preconditioning (RIPC) has multi-organ protective effect in cemented hip arthroplasty patients.",[292,293,294,295],"Osteoarthritis, Hip","Cardiovascular Diseases","Bone Cement Implantation Syndrome","Kidney Diseases","2024-04-03",{"date":298,"type":36},"2024-04-04",{"date":300,"type":36},"2024-03-20",{"date":302,"type":21},"2027-03",{"name":42,"class":43},""]